.Amgen has discussed (PDF) the 1st phase 3 information on its $400 thousand chronic eczema medicine,...
.Biogen as well as UCB's rely on developing in to period 3 on the back of an unsuccessful study look...
.Italian biotech Aptadir Rehabs has actually released with the pledge that its pipe of preclinical R...
.Surge Lifestyle Sciences has actually satisfied its own goal in a Duchenne muscular dystrophy (DMD)...
.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, using up...
.Achilles Therapeutics has destroyed its technique. The British biotech is actually stopping work on...
.Aligos Rehabs is trumpeting a midstage win in metabolic-dysfunction linked steatohepatitis (MASH) a...
.Basilea Pharmaceutica's job establishing new antifungals has acquired a considerable improvement fr...
.Possessing presently scooped up the USA liberties to Capricor Rehabs' late-stage Duchenne muscle dy...
.After pushing back the choice date for Applied Rehabs' metabolic disorder medicine govorestat, the ...